Navigation Links
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009
Date:8/13/2009

617-801-6888 (international callers), using passcode 53658791.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein development experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to business strategies, plans and objectives of management and our strategic review process, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, we may be unsuccessful in identifying or reaching agreement with acquisition or merger candidates, our expenses may be higher than anticipated and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2008. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

                      INSMED INCORPORATED
                   Consolidated Balance Sheets
        (in thousands, except share and per share data)

             
'/>"/>
SOURCE  Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 

Related medicine news :

1. Insmed Provides Update on Supply of IPLEX(TM)
2. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
3. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
4. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
5. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
6. Insmed to Present at Upcoming Healthcare Conferences
7. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
8. Westaim announces 2009 second quarter results
9. eDiets.com(R) Announces Q2 2009 Results
10. Nutrition 21 Announces Preliminary Fourth Quarter Financial Update Also Announces Negotiations on Notes due August 25, 2009
11. Procter & Gamble Announces Appointment of Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Researchers from the School of ... in the UK are today,encouraging families worldwide ... Year following concerning research* that shows two-thirds of ... a family (68%), with the,Portuguese being the least ... together. , According to ...
(Date:12/17/2009)... over the past three years and what has driven these changes ... ... Morehead, the human capital research firm, will host a webinar titled ... free hour-long webinar will be broadcast on Wednesday, January 27, 2010 ... Morehead’s SVP, Consulting Services and Trevor Byrd, Ph.D., a Morehead Consultant, ...
(Date:12/17/2009)... Healthcare Cost/Risk Analysis reports, activity measures and outcomes reporting to ... toward reduced claim costs and positive return on investment over ... ... Jacksonville, FL (PRWEB) December 17, 2009 -- ... in clinical/claims based cost risk analysis along with personalized nurse ...
(Date:12/16/2009)... -- If proposed health care legislation is enacted, ... insurance system. Approximately 18.4 million Californians and 161 ... upon employer-based insurance for their health care coverage. ... reform legislation entail specific requirements for employer-based insurance. ... for firms that currently comply with most new ...
(Date:12/16/2009)... Annual Gala Raises Significant Funds to Benefit of Children ... Christine Taylor, Gary Cole and Zachary Levi Join ... ,, LOS ANGELES, Dec. 16 At its ... three remarkable individuals. Hasbro President & CEO ... Award in recognition of his far-reaching philanthropic leadership ...
Breaking Medicine News(10 mins):Health News:The Family Walk - a Dying Tradition Around the World? 2Health News:Morehead Presents Webinar on "The State of Employee Engagement: A Year in Review" 2Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5
... Light of New Evidence Showing the,Benefits of UV ... Today, the Indoor,Tanning Association (ITA) launched an ... and criticizing,dermatologists and the sunscreen and cosmetics industries ... advertising blitz begins with a full-page print ad ...
... Md. (March 26, 2008) -- The American Physiological Society ... the 2008 Henry Pickering Bowditch Memorial Award for early-career ... 42 years whose accomplishments are both original and outstanding. ... a professor of pharmacology and toxicology, has focused her ...
... Visiprise, Inc., a leader in,manufacturing execution systems (MES) ... named to START-IT magazine,s START-IT 125 list., ... editors and editorial advisors,of START-IT magazine to recognize ... market., Visiprise,s flagship solution, Visiprise Manufacturing, is ...
... Needed, Experts Say, PHILADELPHIA, March 26 ... group of healthcare leaders based at the,University of ... convene a,special conference to address the national shortage ... cannot be maintained, let alone,expanded, unless we educate ...
... 26 WPCS International,Incorporated (Nasdaq: WPCS ... specialty communication systems and wireless infrastructure, has,announced ... awarded approximately,$12 million in new contracts., ... for The University of,Connecticut, The Mashantucket Pequot ...
... ... BIG HORN, Wyo., March 26 Gourmetceuticals, LLC, ... for use in foods and beverages, today announced ... booster, and,PPL-240, an antioxidant, will be presented at ...
Other Medicine News:Health News:Indoor Tanning Association Launches Campaign Attacking Melanoma Hype 2Health News:MSU professor earns Bowditch Award for work on hypertension 2Health News:MSU professor earns Bowditch Award for work on hypertension 3Health News:Visiprise Named One of the Top Manufacturing Technology Providers 2Health News:Council Calls on White House to Convene Conference on Physician and Nurse Supply 2Health News:WPCS Announces $12 Million in New Projects 2Health News:Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008 2
(Date:12/16/2009)... -- Sanofi Pasteur, the vaccines ... that it has entered into an exclusive, ... and commercialize its prophylactic vaccine against ... or MRSA. MRSA are responsible for ... to as multidrug-resistant Staphylococcus aureus ...
(Date:12/16/2009)... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... today announced top-line efficacy and safety results from ... the treatment of Peyronie,s disease. Peyronie,s disease is ... the shaft of the penis, which can distort ... impossible in advanced cases. The Phase 2b study, ...
(Date:12/16/2009)... WOONSOCKET, R.I., Dec. 16 CVS/pharmacy and ... stores are now offering H1N1 vaccine in 20 ... locations priority restrictions for receiving H1N1 vaccines continue, ... to be eligible to receive the shot while ... has been restocked and is available at MinuteClinic ...
Breaking Medicine Technology:Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 1Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 2Atrial fibrillation in endurance athletes still poses problems for sports cardiologists 49549 3METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 1METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 2Does Location Affect Kids Weight 3F 49542 1Does Location Affect Kids Weight 3F 49542 2
... a study published in The American Journal of ... Clinic psychiatrist Mark Frye, M.D., attempted to identify what ... to experience treatment-emergent mania (TEM).Bipolar disorder, also known as ... mood instability that can be serious and disabling. The ...
... for Type 2 Diabetes-PLYMOUTH MEETING, Pa., Feb. 10 ... promising preliminary Phase 1b clinical data for trodusquemine (MSI-1436), ... lead drug candidate for the treatment of type 2 ... CEO of Genaera, presented data from the first of ...
Other Medicine Technology:Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 2Study Suggests New Treatment Approach May be Needed for Management of Depression in Some People With Bipolar Disorder 3Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 2Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436) 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: